Cargando…

Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review

Hepatocellular carcinoma (HCC) ranks third in overall global cancer-related mortality. Symptomatic presentation often means advanced disease where potentially curative treatment options become very limited. Numerous international guidelines propose the routine monitoring of those with the highest ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimhofer, T, Fye, H, Taylor-Robinson, S, Thursz, M, Holmes, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385954/ https://www.ncbi.nlm.nih.gov/pubmed/25826224 http://dx.doi.org/10.1038/bjc.2015.38

Ejemplares similares

Hepatocellular Carcinoma: a Comprehensive Review of Biomarkers, Clinical Aspects, and Therapy
por: Tunissiolli, Nathalia Martines, et al.
Publicado: (2017)

(1)H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites
por: Zennaro, Lucio, et al.
Publicado: (2020)

Metabonomics and intensive care
por: Antcliffe, David, et al.
Publicado: (2016)

Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR
por: Fathi, Fariba, et al.
Publicado: (2013)

Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations
por: Fye, Haddy K. S., et al.
Publicado: (2013)

Metabonomics window into plateau hypoxia
por: Chang, Yue, et al.
Publicado: (2019)

The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery
por: Shen, Eric Yi-Liang, et al.
Publicado: (2023)

Correction: Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations
por: Fye, Haddy K. S., et al.
Publicado: (2013)

Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis
por: Yang, Jianrong, et al.
Publicado: (2021)

Proteome Analyses of Hepatocellular Carcinoma
por: Megger, Dominik A., et al.
Publicado: (2014)

Metabonomics-based omics study and atherosclerosis
por: Wu, Duo-jiao, et al.
Publicado: (2011)

The Quest for Relevant Hepatocellular Carcinoma Biomarkers
por: Kim, Jin U., et al.
Publicado: (2017)

Clinical and Epidemiological Metabonomics
por: Ala-Korpela, Mika, et al.
Publicado: (2011)

Metabonomics Research Progress on Liver Diseases
por: Yu, Mengqian, et al.
Publicado: (2017)

System-based proteomic and metabonomic analysis of the Df(16)A(+/−) mouse identifies potential miR-185 targets and molecular pathway alterations
por: Wesseling, H, et al.
Publicado: (2017)

The Use of Urine Proteomic and Metabonomic Patterns for the Diagnosis of Interstitial Cystitis and Bacterial Cystitis
por: Van, Que N., et al.
Publicado: (2004)

Monitoring Healthy Metabolic Trajectories with Nutritional Metabonomics
por: Collino, Sebastiano, et al.
Publicado: (2009)

Progress in Metabonomics of Type 2 Diabetes Mellitus
por: Ma, Quantao, et al.
Publicado: (2018)

The utility of biomarkers in hepatocellular carcinoma: review of urine-based (1)H-NMR studies – what the clinician needs to know
por: Cartlidge, Caroline R, et al.
Publicado: (2017)

Can joint fluid metabolic profiling (or “metabonomics”) reveal biomarkers for osteoarthritis and inflammatory joint disease?: A systematic review
por: Akhbari, Pouya, et al.
Publicado: (2020)

Metabonomics in toxicity assessment /
Publicado: (2005)

Metabonomics in Gastroenterology and Hepatology
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2019)

Biomarkers for Hepatocellular Carcinoma
por: Behne, Tara, et al.
Publicado: (2012)

Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
por: Desai, Aakash, et al.
Publicado: (2019)

The Applications and Obstacles of Metabonomics in Traditional Chinese Medicine
por: Liu, Ping, et al.
Publicado: (2012)

Calcium-deficiency assessment and biomarker identification by an integrated urinary metabonomics analysis
por: Wang, Maoqing, et al.
Publicado: (2013)

IBD metabonomics predicts phenotype, disease course, and treatment response
por: Bjerrum, Jacob T., et al.
Publicado: (2021)

Biomarkers for Hepatocellular Carcinoma
por: Lou, Jiatao, et al.
Publicado: (2017)

Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review
por: Daher, Saleh, et al.
Publicado: (2017)

Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review
por: Jeong, Woo Kyoung
Publicado: (2023)

A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma
por: Tojjari, Alireza, et al.
Publicado: (2023)

Metabonomics: Mining for Metabolites in Biofluids
Publicado: (2002)

Performance of metabonomic serum analysis for diagnostics in paediatric tuberculosis
por: Andreas, Nicholas J., et al.
Publicado: (2020)

Immune-based therapies for hepatocellular carcinoma
por: Pinato, David J., et al.
Publicado: (2020)

Biological Responses to Perfluorododecanoic Acid Exposure in Rat Kidneys as Determined by Integrated Proteomic and Metabonomic Studies
por: Zhang, Hongxia, et al.
Publicado: (2011)

Integrative analysis of proteomic and metabonomics data for identification of pathways related to Rhizoma Paridis-induced hepatotoxicity
por: Zhao, Chongjun, et al.
Publicado: (2020)

Deciphering the Metabolic Pathway Difference Between Saccharopolyspora pogona and Saccharopolyspora spinosa by Comparative Proteomics and Metabonomics
por: Rang, Jie, et al.
Publicado: (2020)

Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice
por: Wei, Tingting, et al.
Publicado: (2015)

Bioactive Food Components and Cancer-Specific Metabonomic Profiles
por: Kim, Young S., et al.
Publicado: (2011)

A semiparametric modeling framework for potential biomarker discovery and the development of metabonomic profiles
por: Ghosh, Samiran, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_7ckaqg19d5d9dqnubb49cbp6h0